AMA Supports Clinically Appropriate Use of Next-Generation Genome Sequencing | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

AMA Supports Clinically Appropriate Use of Next-Generation Genome Sequencing

November 13, 2012
by Gabriel Perna
| Reprints

Chicago-based physician advocacy group, the American Medical Association (AMA) had a policy-making meeting this week and recognized the ability to integrate next-generation genome sequencing technologies into a clinical setting. The AMA said it supports “regulatory policy that protects patient rights and confidentiality, and enables physicians to access and use such diagnostic tools as clinically appropriate.”

“Advances in DNA sequencing technology offer patients and physicians a new diagnostic tool to help improve health outcomes, but clinical challenges must be addressed to realize the full potential benefits of this technology,” AMA Board Member Robert M. Wah, M.D., said in a statement

“While cost and time barriers to genetic sequencing have been reduced, important privacy, practice, payment and regulatory issues, including how to compensate physicians and other health care professionals for the considerable work-related demands required, must still be addressed.”  AMA also supports policy that informs and educates physicians and trainees on the clinical uses of these technologies.

In addition, the AMA supported policy that calls on the Centers for Medicare & Medicaid Services (CMS) to suspend the implementation of the ICD-10 code set. According to a report from American Medical News, one AMA delegate said the group will continue to fight for physicians when it comes to being over-burdened by the ICD-10 regulatory requirement.

Topics

News

Ohio HIE Has Sent 8.1 Million Results

CliniSync, the nonprofit statewide health information exchange for Ohio, offered a year-end 2017 report, noting that almost all of its 157 hospitals are in production or live, sending results and reports to practices.

Allscripts Ransomware Update: Outages Expected through Monday

The Chicago-based Allscripts, one of the most prevalent EHR (electronic health record) vendors in the world, is still working to restore some of its IT systems following a ransomware attack last week.

Study: Inaccuracies in EHR Problem Lists Pose Problems for Risk Adjustment

Inaccuracies in EHR problem list–based comorbidity data can lead to incorrect determinations of case mix, according to a study that took place at two southern California Veterans Affairs (VA) medical centers.

Survey: 42 Percent of Companies Have Experienced Ransomware Attacks

The percentage of global companies reporting financially motivated cyber-attacks has doubled over the past two years, with 50 percent of surveyed companies associating ransom as the leading motivation for attacks over other attacks, including insider threats, hacktivism and competition, according to a report by Radware.

Allscripts Acknowledges Ransomware Attack, Says Impact is “Limited”

Health IT vendor Allscripts has acknowledged that it is investigating a ransomware incident that has impacted a limited number of its applications.

AHRQ to Fund Patient Safety Learning Laboratories

The federal Agency for Healthcare Research Quality plans to spend up to $5 million in fiscal 2018 to support as many as eight patient safety learning laboratories.